A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis
Public ClinicalTrials.gov record NCT01750190. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of Roxadustat (FG-4592) for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether roxadustat is safe and effective in the treatment of anemia in participants with chronic kidney disease and not on dialysis.
Study identification
- NCT ID
- NCT01750190
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 922 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 5, 2012 (Actual)
- Primary completion
- Sep 24, 2018 (Actual)
- Completion
- Sep 24, 2018 (Actual)
- Last update posted
- Oct 1, 2021
2012 – 2018
United States locations
- U.S. sites
- 55
- U.S. states
- 21
- U.S. cities
- 51
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site | Huntsville | Alabama | 35801 | — |
| Investigational Site | Tempe | Arizona | 85284 | — |
| Investigational Site | Alhambra | California | 91801 | — |
| Investigational Site | Chula Vista | California | 91910 | — |
| Investigational Site | Inglewood | California | 90301 | — |
| Investigational Site | La Mesa | California | 91942 | — |
| Investigational Site | La Palma | California | 91324 | — |
| Investigational Site | Lynwood | California | 90262 | — |
| Investigational Site | Northridge | California | 91325 | — |
| Investigational Site | Paramount | California | 90723 | — |
| Investigational Site | Riverside | California | 92503 | — |
| Investigational Site | Roseville | California | 95661 | — |
| Investigational Site | San Dimas | California | 91773 | — |
| Investigational Site | Whittier | California | 90603 | — |
| Investigational Site | Coral Gables | Florida | 33134 | — |
| Investigational Site | Cutler Bay | Florida | 33157 | — |
| Investigational Site | Hialeah | Florida | 33016 | — |
| Investigational Site | Miami | Florida | 33015 | — |
| Investigational Site | Miami | Florida | 33122 | — |
| Investigational Site | Miami | Florida | 33135 | — |
| Investigational Site | Miami | Florida | 33150 | — |
| Investigational Site | Ocala | Florida | 34471 | — |
| Investigational Site | Pembroke Pines | Florida | 33028 | — |
| Investigational Site | South Miami | Florida | 33143 | — |
| Investigational Site | Winter Park | Florida | 32789 | — |
| Investigational Site | Augusta | Georgia | 30909 | — |
| Investigational Site | Caldwell | Idaho | 83605 | — |
| Investigational Site | Shreveport | Louisiana | 71101 | — |
| Investigational Site | Baltimore | Maryland | 21218 | — |
| Investigational Site | Boston | Massachusetts | 02215 | — |
| Investigational Site | Detroit | Michigan | 48202 | — |
| Investigational Site | Flint | Michigan | 48503 | — |
| Investigational Site | Flint | Michigan | 48532 | — |
| Investigational Site | Pontiac | Michigan | 48341 | — |
| Investigational Site | Roseville | Michigan | 48066 | — |
| Investigational Site | St Louis | Missouri | 63110 | — |
| Investigational Site | New Brunswick | New Jersey | 08903 | — |
| Investigational Site | Albuquerque | New Mexico | 87109 | — |
| Investigational Site | Mineola | New York | 11501 | — |
| Investigational Site | The Bronx | New York | 10461 | — |
| Investigational Site | Asheville | North Carolina | 28801 | — |
| Investigational Site | Raleigh | North Carolina | 27609 | — |
| Investigational Site | Rocky Mount | North Carolina | 27804 | — |
| Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Investigational Site | Beaver | Pennsylvania | 15009 | — |
| Investigational Site | Orangeburg | South Carolina | 29118 | — |
| Investigational Site | Sumter | South Carolina | 29150 | — |
| Investigational Site | Nashville | Tennessee | 37232 | — |
| Investigational Site | Arlington | Texas | 76015 | — |
| Investigational Site | Corsicana | Texas | 75110 | — |
| Investigational Site | Dallas | Texas | 75246 | — |
| Investigational Site | Houston | Texas | 77030 | — |
| Investigational Site | San Antonio | Texas | 78229 | — |
| Investigational Site | Fairfax | Virginia | 22033 | — |
| Investigational Site | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 90 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01750190, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 1, 2021 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01750190 live on ClinicalTrials.gov.